Active	Status	Sponsor type	Region	Phase	Filter
2 Active 0 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Malengera, Victor
NCT05067166: Open-Label Expanded Access for Ebola-Infected Patients to Receive Human MAb Ansuvimab As Therapeutic or for HR PEP	Available	N/A		NA	Ansuvimab, mAb114, Ebanga	Ridgeback Biotherapeutics, LP, Institut National de Recherche Biomédicale. Kinshasa, République Démocratique du Congo	Ebola Virus Disease
Lakoh, Sulaiman
NCT05067166: Open-Label Expanded Access for Ebola-Infected Patients to Receive Human MAb Ansuvimab As Therapeutic or for HR PEP	Available	N/A		NA	Ansuvimab, mAb114, Ebanga	Ridgeback Biotherapeutics, LP, Institut National de Recherche Biomédicale. Kinshasa, République Démocratique du Congo	Ebola Virus Disease